Acetylglutamine for injection
Function and Efficacy
After passing through the blood-brain-spinal fluid barrier, acetylglutamine decomposes into glutamate and g-aminobutyric acid (GABA): glutamate is involved in information transmission in the central nervous system; g-aminobutyric acid can antagonize the excitotoxic effects of glutamate, improve nerve cell metabolism, maintain nerve stress resistance, reduce the effects of blood ammonia, and improve brain function.
Ingredients
The main ingredient of this product is acetylglutamine.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| AceglutamideIngredients |
After passing through the blood-brain-spinal fluid barrier, it is decomposed into glutamate and g-aminobutyric acid (GABA): glutamate is involved in information transmission in the central nervous system; g-aminobutyric acid can antagonize the excitotoxic effects of glutamate, improve nerve cell metabolism, maintain nerve stress resistance, reduce the effects of blood ammonia, and improve brain function. More |
2490-97-3 | 6 |
Appearance
This product is white or off-white freeze-dried block.
Indication
It is used for coma caused by brain trauma, coma caused by neurosurgery, hepatic coma, hemiplegia and high paraplegia, sequelae of polio, neuralgia and low back pain, etc.
Usage and Dosage
Intramuscular injection: 100-600 mg per day; children's dose should be reduced. Intravenous drip: Dissolve in 250 ml of 5% or 10% glucose injection and drip slowly.
Adverse Reactions
No adverse reactions were reported.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Children should reduce the dosage or follow the doctor's advice when using this product. Precautions for pregnancy and lactation: Not clear yet. Precautions for the elderly: There is no research data on the use of this product in elderly patients. Please refer to [Usage and Dosage] and other items.
Drug Interactions
Not yet clear.
Storage
Keep in a light-proof and airtight container.
Packaging Specification
0.25g
Validity Period
Tentative 18 months
Manufacturer
Harbin Medisan Pharmaceutical Co., Ltd.
-
Founded in:
1996-06-21 -
Address:
Beijing Road, Limin Development Zone, Harbin -
Tax NO.:
91230100607168790X -
Registered Funds:
316.35755 million yuan -
Website:
-
Email: